Stevia Extract and Glucose Homeostasis
Launched by LIVERPOOL HOPE UNIVERSITY · Apr 2, 2020
Trial Information
Current as of June 10, 2025
Withdrawn
Keywords
ClinConnect Summary
The study is a three-arm crossover trial involving participants attending the Lab on 3 different occasions (separated by 3-5 day washout period), where they will be administered water, sugar solution (65g), water and stevia extract (5g) solution. The solution will be followed by a consumption of a fixed meal (after 30 minutes). Breakfast will be standardised. Capillary blood glucose will be collected every 30 min until 2 hours post meal. Venous blood samples will be collected before the intake of the solution and at 2 hours after meal intake.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-65 years
- • BMI 27-40 Kg/m2
- • Males and females
- Exclusion Criteria:
- • Athletes
- • Pregnant or breastfeeding women
- • Patients with chronic disease (diabetes, CVD etc...).
About Liverpool Hope University
Liverpool Hope University is a prestigious higher education institution dedicated to fostering research and innovation across various disciplines, including health and clinical sciences. As a sponsor of clinical trials, the university emphasizes a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry. With a focus on ethical standards and collaboration with healthcare professionals, Liverpool Hope University aims to contribute to the development of effective therapies and interventions, positioning itself as a leader in the field of clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liverpool, , United Kingdom
Patients applied
Trial Officials
Farzad Amirabdollahian, PhD
Study Chair
Liverpool Hope University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials